Akero Looks To Double Its Cash Following Strong Phase IIb NASH Data

 
• By Joseph Haas
  
Liver disease
Akero is raising significant funds to finance NASH Phase III plans • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business